DGX Stock Overview
Provides diagnostic testing and services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$161.16 |
| 52 Week High | US$162.88 |
| 52 Week Low | US$123.04 |
| Beta | 0.89 |
| 11 Month Change | 9.36% |
| 3 Month Change | 5.44% |
| 1 Year Change | 18.72% |
| 33 Year Change | 7.78% |
| 5 Year Change | 50.43% |
| Change since IPO | 4,504.57% |
Recent News & Updates
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)
Nov 12
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Oct 25Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Oct 24Recent updates
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)
Nov 12Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Oct 25Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Oct 24Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E
Oct 23Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly
Oct 15These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Shareholder Returns
| DGX | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.4% | -4.6% | -1.2% |
| 1Y | 18.7% | 1.1% | 30.4% |
Return vs Industry: DGX exceeded the US Healthcare industry which returned 1.1% over the past year.
Return vs Market: DGX underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| DGX volatility | |
|---|---|
| DGX Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DGX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DGX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 44,000 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| DGX fundamental statistics | |
|---|---|
| Market cap | US$17.99b |
| Earnings (TTM) | US$838.00m |
| Revenue (TTM) | US$9.54b |
21.5x
P/E Ratio1.9x
P/S RatioIs DGX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGX income statement (TTM) | |
|---|---|
| Revenue | US$9.54b |
| Cost of Revenue | US$6.39b |
| Gross Profit | US$3.15b |
| Other Expenses | US$2.31b |
| Earnings | US$838.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.51 |
| Gross Margin | 32.97% |
| Net Profit Margin | 8.79% |
| Debt/Equity Ratio | 90.3% |
How did DGX perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield39%
Payout RatioDoes DGX pay a reliable dividends?
See DGX dividend history and benchmarks| Quest Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Jan 14 2025 |
| Dividend Pay Date | Jan 29 2025 |
| Days until Ex dividend | 54 days |
| Days until Dividend pay date | 69 days |
Does DGX pay a reliable dividends?
See DGX dividend history and benchmarks